RE:RE:RE:RE:Immune cell that can kill most cancersHi Yaine .. they do say they "hoped" to start but that doesn't assure that they will and in many of my past post I have said TLT needs to prove what they have and stay ahead of the competition, please don't confuse admiration of what this company is doing as behind blindly focused. However I do agree with you that speed is essential in PH2 that Theralase is conducting. All companies regardless if health or technology or general production have minor delays & setbacks and we all know that you deal with it and keep going. So far with Theralase satisfying FDA's need for clarity is a minor problem.
Yajne wrote
Yes datawork, the subject of competition has been raised many times over past years (incl my concerns), but you will find most of this board with their MYOPIC heads firmly planted in the sand ostrich style with the view that TLT has no serious competition. Go figure that... datawork
investclub wrote: Interesting nemo3 I am not well versed in medical science although in the 6 months I have been here my understanding of the research and length of time to advance to human clinical trials take years. On a wild guess I would put this UK company into a 5 to 10 year span for human trial to commence.
They mentioned that they hoped to start clinical trials starting in November on critical patients. One more reason this train needs to leave the station ASAP. There is a world of competition out there.